Renaissance Technologies (RenTech)'s IMDX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 13,400 shares of Insight Molecular Diagnostics Inc. (IMDX) worth $100,500, representing 0.00% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 8 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in IMDX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 26,100 shares. Largest reduction occurred in Q3 2024, reducing 10,418 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Insight Molecular Diagnostics (IMDX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Insight Molecular Diagnostics (IMDX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -10,200 | Reduce 43.22% | 13,400 | $7.50 |
| Q3 2025 | -2,500 | Reduce 9.58% | 23,600 | $3.32 |
| Q2 2025 | +26,100 | New Buy | 26,100 | $3.02 |
| Q3 2024 | -10,418 | Sold Out | 0 | $0.00 |
| Q2 2024 | -1,800 | Reduce 14.73% | 10,418 | $2.95 |
| Q1 2024 | -500 | Reduce 3.93% | 12,218 | $2.95 |
| Q4 2023 | +500 | Add 4.09% | 12,718 | $2.52 |
| Q3 2023 | +12,218 | New Buy | 12,218 | $3.11 |
Renaissance Technologies (RenTech)'s Insight Molecular Diagnostics Investment FAQs
Renaissance Technologies (RenTech) first purchased Insight Molecular Diagnostics Inc. (IMDX) in Q3 2023, acquiring 12,218 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Insight Molecular Diagnostics Inc. (IMDX) for 8 quarters since Q3 2023.
Renaissance Technologies (RenTech)'s largest addition to Insight Molecular Diagnostics Inc. (IMDX) was in Q2 2025, adding 26,100 shares worth $78,822.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 13,400 shares of Insight Molecular Diagnostics Inc. (IMDX), valued at approximately $100,500.
As of the Q4 2025 filing, Insight Molecular Diagnostics Inc. (IMDX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Insight Molecular Diagnostics Inc. (IMDX) was 26,100 shares, as reported at the end of Q2 2025.